PubMed Health⌕ Search

Biomedical subjects

L M Crawford

Publications and source records attributed to L M Crawford.

32 records · Page 2Linked to original sources
PubMed1978

[Not Available].

Explore the source record for details and available documents.

France↗
PubMed1977

[Not Available].

Explore the source record for details and available documents.

History, Modern 1601-↗
PubMed1977

The role of the thoracic compression reflex in the Heimlich Maneuver.

Using the dog as an experimental model, the relationship of the Thoracic Compression Reflex (TCR) to the Heimlich Maneuver (HM) was examined. TCR was equally effective as lateral chest compression in relieving artificially induced choke. Destruction of the TCR by vagotomy rendered relief of choke by HM ineffectual in 5 of 8 dogs. It was concluded TCR may be a factor in HM, but that mechanical compression of the lungs is also involved.

Airway Obstruction↗
PubMed1977

Hypocalcemic effect of aminoglycoside antibiotics in the dairy cow.

The effect of the parenteral administration of aminoglycoside antibiotics on the blood calcium concentration in dairy cows was investigated. Gentamicin was tested in vitro in blood drawn from cows, dihydrostreptomycin was tested in nonlactating cows and neomycin was tested in postpartum cows. The total and bound calcium fractions were significantly reduced by all three antibiotics. No change occurred in the unbound calcium fractions. Caution is advised in the use of these drugs in postpartum cows, especially those with a history of milk fever.

Aminoglycosides↗
PubMedDate not supplied

Comparison of motility and membrane integrity to assess rat sperm viability.

Rat sperm motility and membrane integrity were compared as endpoints for viability. Sperm motility was measured by computer-assisted semen analysis (CASA), whereas membrane integrity was assessed by flow cytometric analysis of sperm stained with two nucleic acid stains, SYBR-14 and propidium iodide. The two techniques were compared in experiments that examined sperm viability over time and by analysis of known mixtures of control and freeze/thaw-killed sperm. Results from the two approaches were quantitatively very similar. Sperm from rats treated with dibromoacetic acid (600 or 1200 mg/kg) or alpha-chlorhyrin (100 mg/kg) were also analyzed. Neither technique detected a treatment-related effect with dibromoacetic acid. CASA identified a significant decrease in sperm motility in alpha-chlorhyrin-treated rats, whereas flow cytometric analysis did not find a measureable change in sperm membrane integrity. Because decreases in sperm motility would be expected to directly affect fertility, CASA may be a more robust endpoint for risk assessment in reproductive toxicology studies than flow cytometric analysis of membrane integrity.

Acetates↗
PubMedDate not supplied

Efficacy of insulin pump therapy: mealtime delivery is the key factor.

OBJECTIVE: To investigate, in a clinical setting, the effect of implementation of continuous subcutaneous insulin infusion (CSII) on control of plasma glucose and to identify factors associated with improved glycemic control in patients with type 1 diabetes mellitus. METHODS: Nineteen patients (16 women and 3 men) with type 1 diabetes were studied retrospectively. Their mean age was 42.6 years (range, 30 to 58), and the mean duration of diabetes was 21 years. The subjects underwent follow-up for a mean of 14 months after conversion to CSII therapy. With use of paired t tests, pre-CSII and follow-up data were evaluated relative to changes in weight, insulin dosing, and glycosylated hemoglobin (HbA(1c)). RESULTS: At follow-up, the total daily dose of insulin had decreased by 18%, from a baseline mean value of 45.2 IU to 37.1 IU (P = 0.02). HbA(1c) was reduced from 8.4% to 7.7% (P<0.01). The total daily insulin-to-weight ratio also significantly decreased from 0.66 IU/kg to 0.53 IU/kg (P<0.05). Before insulin pump use, the regular/NPH insulin ratio was 0.5 IU; at follow-up, the pump bolus/basal insulin ratio was 1.0 IU (P = 0.02). No weight gain was observed; the mean weight of the study patients decreased 0.2 kg, from 69.4 kg at baseline to 69.2 kg at follow-up (not significantly different). CONCLUSION: In a clinical setting, CSII therapy in patients with type 1 diabetes improves glycemic control and lowers the total daily basal insulin dose without affecting weight. Improved glycemic control was associated with a shift in insulin therapy from a high percentage of intermediate-acting insulin to a greater percentage of insulin administered in a meal-associated bolus form. This study emphasizes the importance of mealtime insulin adjustment for tight glycemic control in patients using CSII therapy. Future studies evaluating the benefits of decreased total insulin and an increased bolus/basal insulin ratio may be important in helping to understand how to avoid long-term complications of diabetes.

Adult↗